Zhongnan Medical Journal Press

Home Results

A total of 344 result was found. Results that relate to Drug

Design and application scenarios of digital monitoring model for online drug sales——based on Shanghai online drug circulation supervision system

Published on Frontiers in Pharmaceutical Sciences 2026,30(4):707-714.
1798 times 362 times

ZHUANG Wenyi ZHAO Yuxiang FENG Xiao SHEN Kan WANG Haibo GUO Aiwei ZHOU Fengwu WANG Guangping

Drug Online Circulation Digitalization Monitoring Robotic process automation Case Investigation and Handling Database
Details
Expert consensus for off-label drug use of rare diseases (2026 edition)

Published on Chinese Journal of Pharmacoepidemiology 2026,35(5):493-507.
1673 times 484 times

DUAN Yuehan CHEN Chaoyang ZHANG Yu CUI Yi-min WANG Shengfeng DING Jie Working Group of the Expert Consensus for Off-Label Drug Use of Rare Diseases

Rare disease Off-label drug use Expert consensus Thomson evidence grading system
Details
Visualization analysis of off-label drug use of Chinese patent medicine based on CiteSpace software

Published on Chinese Journal of Pharmacoepidemiology 2026,35(5):563-570.
1036 times 277 times

SONG Yifei WANG Hui YANG Wenbao CHEN Xin JIA Shengwei ZHANG Huiyue

Chinese patent medicine Off-label use Bibliometrics Visual analysis Rational drug use
Details
Environmental chemical exposure and antidepressant efficacy: mechanisms and advances in precision pharmacology prediction models

Published on Chinese Journal of Pharmacoepidemiology 2026,35(5): 579-588.
991 times 232 times

WANG Pei CHEN Wanying SHANG Nan ZHANG Ruifen

Antidepressants Environmental exposure Blood-brain barrier Drug efficacy Envir-onmental chemical pollutants Precision pharmacology
Details
Establishment of drug utilization evaluation criteria for bemiparin sodium and its clinical application

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):820-827.
852 times 161 times

YE Chenli HONG Weimin HAN Yutong CAO Weiling

Bemiparin sodium Drug utilization evaluation Delphi method Off-label use Rational drug use
Details
Research progress on multidrug resistance mechanism of non-small cell lung cancer and reversal effect of active ingredients of traditional Chinese medicine

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):857-866.
807 times 148 times

ZHENG Wanrong LAI Fobao

Tumor multidrug resistance Non-small cell lung cancer Active components of traditional Chinese medicine Resistance reversal Non-coding RNA Programmed cell death
Details
Research progress on traditional Chinese medicine combined with chemotherapeutic drugs in the treatment of colorectal cancer

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):867-875.
780 times 133 times

LIU Qingrui WANG Lu CHEN Hao WANG Pei HUANG Chuyue ZHOU Bingwen DONG Yujing FAN Zhimin

Colorectal cancer Traditional Chinese medicine Enhancing efficacy and reducing toxicity Cell cycle Autophagy Apoptosis Multidrug resistance Immune microenvironment
Details
Research progress on optimized technical paths of meloxicam dosage forms

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):876-884.
710 times 137 times

YANG Jie YUAN Jing XU Shaohua LIAO Zongquan XIAO Gaofeng QU Longmei

Meloxicam Dosage form Drug delivery system Targeted preparations Sustained-release preparations Cyclooxygenase-2
Details
Interpretation of the Guiding Principles of Good AI Practice in Drug Development jointly released by FDA and EMA

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):885-894.
1589 times 558 times

ZHANG Hua LI Pengfei FU Hongjun

U.S. Food and Drug Administration European Medicines Agency Ar-tificial intelligence Drug development Guide principles Regulatory science
Details
Analysis of one case of almolertinib-induced interstitial lung disease in a lung cancer patient

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):895-900.
815 times 152 times

FAN Xinxing LI Ling ZHENG Menying BAI Juan

Almonertinib Interstitial lung disease Lung cancer Adverse drug reaction
Details
Development of a predictive model for the risk of antimicrobial drug-induced thrombocytopenia using 5 machine learning algorithms

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):625-634.
306 times 79 times

WANG Min SHEN Xiaoyan

Machine learning Antimicrobial drugs Thrombocytopenia Prediction model Risk factors Extreme gradient boosting SHapley Additive exPlanation
Details
Post-marketing safety evaluation of nirsevimab based on the FAERS database

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):653-659.
381 times 82 times

NIU Rui LIU Wei ZHAO Kai ZHANG Wenqian ZHAO Fang

Nirsevimab Respiratory syncytial virus Pharmacovigilance Adverse drug reactions
Details
Real-world study of generic versus branded meropenem in the treatment of hospital-acquired pneumonia patients with traumatic brain injury

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):660-668.
310 times 85 times

SHEN Jie TANG Lian CHEN Xianglong YANG Lijuan LI Tongtong MA Mian DENG Peng XU Jinhui

Meropenem Generic drug Branded drug Hospital-acquired pneumonia Traumatic brain injury Efficacy Safety Economy
Details
Rosuvastatin-induced ocular myasthenia gravis: a case report

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):700-704.
341 times 79 times

WEN Chao WANG Min LI Yali WU Panting TAO Xuxia TANG Xiaoxia

Rosuvastatin Statins Ocular myasthenia gravis Adverse drug reaction
Details